New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For SNE;CAT;HES;BBY;KERX;FURX;JOSB;ROP;MW;RPRX;BBBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | all recent news | >>
September 23, 2014
13:55 EDTSNESamsung to stop selling laptops in Europe, PC Advisor says
Subscribe for More Information
12:51 EDTBBBYBed Bath & Beyond technical notes ahead of earnings
In the prior three months the shares have moderately outperformed the broader averages. The trend has been bullish, with very little volatility, over the interval. The stock is trading below the middle of its range for the last 52 weeks. There has been a strong degree of resistance at the $65 area since mid April of this year. On strongly bullish news, a breakout above $65 could turn the intermediate-term trend to bullish from neutral. Additional upside objectives could be at the following resistance levels on an increasing band of positive surprises: $67.25, $68.10, and $69.80. If the news is not bullish, the recent uptrend in the prior three months could be broken. A move that remains below $62 would break the short-term uptrend. Additional downside objectives could be at the following support levels on a progressive band of misses: $61.27, $59.61, and $57.80.
10:02 EDTBBBYOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Analog Devices (ADI) downgraded to Neutral from Overweight at JPMorgan... Bed Bath & Beyond (BBBY) downgraded to Market Perform at William Blair... Cameco (CCJ) downgraded to Neutral from Buy at BofA/Merrill... Clorox (CLX) downgraded to Neutral from Buy at Citigroup... Concur (CNQR) downgraded to Neutral from Buy at Roth Capital... Del Frisco's (DFRG) downgraded at Sterne Agee... Dick's Sporting (DKS) downgraded to Market Perform from Outperform at William Blair... Dresser-Rand (DRC) downgraded to Hold from Buy at KeyBanc... Equinix (EQIX) downgraded to Market Perform from Outperform at Wells Fargo... Fluor (FLR) downgraded at Wells Fargo... Gordmans Stores (GMAN) downgraded at Canaccord... Jacobs Engineering (JEC) downgraded to Market Perform from Outperform at Wells Fargo... Nanometrics (NANO) downgraded to Hold from Buy at Canaccord... ON Semiconductor (ONNN) downgraded to Neutral from Overweight at JPMorgan... Siemens (SIEGY) downgraded to Equal Weight from Overweight at Barclays... Sigma-Aldrich (SIAL) downgraded to Hold from Buy at KeyBanc... Taminco (TAM) downgraded to Hold from Buy at Jefferies... Viasystems (VIAS) downgraded to Hold from Buy at Canaccord... Watsco (WSO) downgraded to Accumulate from Buy at Global Hunter.
07:36 EDTBBBYBed Bath and Beyond weekly volatility elevated into Q2 and outlook
Subscribe for More Information
07:10 EDTBBBYBed Bath & Beyond downgraded to Market Perform at William Blair
Subscribe for More Information
06:08 EDTSNESony Mobile cuts smartphone business personnel by 15%, DigiTimes reports
Subscribe for More Information
05:46 EDTBBBYBed Bath & Beyond downgraded to Market Perform from Outperform at William Blair
Subscribe for More Information
September 22, 2014
13:57 EDTRPRXRepros Therapeutics volatility increases on wide price movement
Repros Therapeutics overall option implied volatility of 128 is above its 26-week average of 89 according to Track Data, suggesting large price movement.
13:49 EDTSNESony confirms October 14 launch for PlayStation TV in U.S.
Sony confirmed in a blog post that PlayStation TV will launch in the U.S. and Canada on October 14 and that "nearly 700 games" will be available at launch. PS TV will be priced starting at $99.99 for the standalone system, or $139.99 for a bundle that includes a Wireless Controller, 8GB memory card, and The LEGO Movie Videogame. Reference Link
09:18 EDTRPRXRepros Therapeutics provides update on Androxal
Subscribe for More Information
07:31 EDTBBBYBed Bath & Beyond Q2 results likely similar to recent quarters, says UBS
UBS said it expects Bed Bath & Beyond's Q2 results to "look a lot like" its recent quarters, reflecting a modest comp sales increase and ongoing gross margin pressure. The firm maintains its Neutral rating and $62 price target on the stock.
07:25 EDTCATCitigroup to hold a conference
Industrials Conference to be held in Boston on September 22-24.
06:44 EDTSNE'The Maze Runner' leads weekend box office sales with $32.5M, WSJ reports
Subscribe for More Information
September 19, 2014
11:11 EDTCATCaterpillar sales trends for August mixed, says Wells Fargo
Subscribe for More Information
11:06 EDTBBBYBed Bath and Beyond weekly volatility elevated into Q2 and outlook
Subscribe for More Information
10:12 EDTSNESony expected to launch SmartEyeglass by end of March, The Verge reports
Sony (SNE) is expected to launch SmartEyeglass, a competitor to Google Glass (GOOG), by the end of March, according to The Verge. Reference Link
09:13 EDTCATCaterpillar reports Machines sales down 10% in three months end August
Subscribe for More Information
September 18, 2014
13:38 EDTRPRXRepros needed unique Androxal label even before ADCOM panel, says Ladenburg
Ladenburg said that given the FDA advisory committee's 20 to 1 vote that it believes the FDA will likely revise testosterone replacement therapy labels to restrict their use in hypogonadal patients with clear etiology. However, Ladenburg added that Repros was always going to have to establish a unique label for Androxal and the firm believes that the company's ongoing and completed trials will provide sufficient data for filing and approval by the FDA in secondary hypogonadism. The firm maintains its Buy rating and $35 price target on Repros.
12:45 EDTRPRXOn The Fly: Midday Wrap
Subscribe for More Information
11:39 EDTSNESony's no-dividend policy could be sign of hope, not doom, Nikkei reports
Subscribe for More Information
<< 1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use